Diko : en:primary non-small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type or classified as nsclc-nos with an explanation

(id=8128651)

en:primary non-small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type or classified as nsclc-nos with an explanation

Catégories

Nom

Informations lexicales

Langue:anglais

Informations sémantiques

source:wiki

Liens externes

›

umls:C3871324

Associations d'idées

[F]

›

366

en:patient offered assistance with end of life issues during the measurement period

•

en:motor speech functional limitation, discharge status, at discharge from therapy or to end reporting

•

en:patient sustained major viscus injury at the time of surgery or subsequently up to 1 month post-surgery

•

en:ct studies performed not reported to a radiation dose index registry, reason not given

•

en:total number of emergency department visits and inpatient hospitalizations equal to or greater than two in the past 12 months or patient not screened, reason not given

•

en:post-partum screenings, evaluations and education not performed

•

en:patient starting antiviral treatment for hepatitis c during the measurement period

•

en:documentation of patient-specific risk assessment with a risk calculator based on multi-institutional clinical data, the specific risk calculator used, and communication of risk assessment from risk calculator with the patient or family not completed

•

en:patient with minor blunt head trauma had an appropriate indication(s) for a head ct

•

en:patient sustained bladder injury at the time of surgery or subsequently up to 1 month post-surgery

•

en:patient treated with a beta-lactam antibiotic as definitive therapy

•

en:statin prescribed at discharge

•

en:patient not discharged to home by post-operative day #7

•

en:improvement in median time from ed arrival to initial ed oral or parenteral pain medication administration not performed for ed admitted patients

•

en:final reports without documentation of one or more dose reduction techniques (e.g., automated exposure control, adjustment of the ma and/or kv according to patient size, use of iterative reconstruction technique)

•

en:preoperative assessment not documented, reason not given

•

en:i intend to report the sinusitis measures group

•

en:chlamydia, gonorrhea and syphilis screening results documented (report when results are present for all of the 3 screenings)

•

en:blood pressure has a systolic value of =140 and a diastolic value of = 90 or systolic value < 140 and diastolic value = 90 or systolic value = 140 and diastolic value < 90

•

en:patient admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision

•

en:one high-risk medication not ordered

•

en:national committee for quality assurance - level 2 medical home

•

en:statin not prescribed for documented reasons (e.g., allergy, medical intolerance)

•

en:spoken language expression functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:spoken language comprehension functional limitation, discharge status, at discharge from therapy or to end reporting

•

en:specimen site other than anatomic location of lung or is not classified as primary non-small cell lung cancer

•

en:shared decision-making including discussion of conservative (non-surgical) therapy (e.g., nsaids, analgesics, weight loss, exercise, injections) prior to the procedure, not documented, reason not given

•

en:services performed by qualified pharmacist in the hospice setting, each 15 minutes

•

en:remission at six months as demonstrated by a six month (+/-30 days) phq-9 score of less than five

•

en:prior thyroid disease diagnosis

•

en:patient whose mode of vascular access is not a catheter at the time maintenance hemodialysis is initiated

•

en:patient underwent abdominal imaging with ultrasound, contrast enhanced ct or contrast mri for hcc

•

en:patient identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method and received brief counseling

•

en:patient did not require a return to the operating room within 90 days of surgery

•

en:patient did not have one dose of meningococcal vaccine on or between the patient's 11th and 13th birthdays

•

en:patients who are currently statin therapy users or received an order (prescription) for statin therapy

•

en:patients in whom mrs score could not be obtained at 90 day follow-up

•

en:p2y inhibitor not prescribed for documented reasons (e.g., allergy, medical intolerance, history of bleed)

•

en:non small cell lung cancer biopsy and cytology specimen report does not document classification into specific histologic type or classified as nsclc-nos with an explanation

•

en:documentation of patient with one or more complications within 90 days

•

en:documentation of at least two attempts to reach the patient to arrange a clinical re-assessment for the appropriateness of filter removal within 3 months of placement

•

en:attention functional limitation, current status at therapy episode outset and at reporting intervals

•

en:aspirin not prescribed for documented reasons (e.g., allergy, medical intolerance, history of bleed)

•

en:all quality actions for the applicable measures in the diabetic retinopathy measures group have been performed for this patient

•

en:transfer of care during an anesthetic or to the intensive care unit

•

en:services performed by volunteer in the hospice setting, each 15 minutes

•

en:pediatric patient with minor blunt head trauma not classified as low risk according to the pecarn prediction rules

•

en:patient receiving maintenance hemodialysis for greater than or equal to 90 days with a catheter as the mode of vascular access

•

en:patients who are evaluated for venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure (e.g. history of dvt, pe, mi, arrhythmia and stroke)

•

en:patients prescribed opiates for longer than six weeks

•

en:motor speech functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:more than one ct scan of the paranasal sinuses ordered or received within 90 days after the date of diagnosis for documented reasons (eg, patients with complications, second ct obtained prior to surgery, other medical reasons)

•

en:individual had a pdc of 0.8 or greater

•

en:incidental thyroid nodule < 1.0 cm noted in report

•

en:documentation of patient survival and absence of stroke following cea

•

en:documentation of patient discharged to home no later than post operative day 2 following cas

•

en:beta-blocker therapy not prescribed, reason not given

•

en:at least two different high-risk medications not ordered

•

en:asthma well-controlled based on the act, c-act, acq, or ataq score and results documented

•

en:all necessary data elements not included, reason not given

•

en:advanced brain imaging (cta, ct, mra or mri) was not ordered

•

en:transesophageal doppler measurement of cardiac output (including probe placement, image acquisition, and interpretation per course of treatment) for monitoring purposes

•

en:the highest fasting or direct ldl-c laboratory test result of 70-189 mg/dl in the measurement period or two years prior to the beginning of the measurement period

•

en:specimen site other than anatomic cutaneous location

•

en:preoperative assessment documented

•

en:photodocumentation of one or more cecal landmarks to establish a complete examination

•

en:patient transferred directly from anesthetizing location to pacu

•

en:patient received one-time screening for hcv infection

•

en:patient not screened for uterine malignancy, or those that have not had an ultrasound and/or endometrial sampling of any kind, reason not given

•

en:patient has been treated with a systemic or biologic medication for psoriasis for at least six months

•

en:patients with 90 day mrs score greater than 2

•

en:patients who were born in the years 1945-1965

•

en:pathology report does not include the pt category and a statement on thickness and ulceration and for pt1, mitotic rate

•

en:one ct scan or no ct scan of the paranasal sinuses ordered within 90 days after the date of diagnosis

•

en:memory functional limitation, discharge status at discharge from therapy or to end reporting

•

en:incidental ct finding: liver lesion = 0.5 cm, cystic kidney lesion < 1.0 cm or adrenal lesion = 1.0 cm

•

en:history of injection drug use

•

en:final reports for ct or mri of the chest or neck or ultrasound of the neck with follow-up imaging recommended

•

en:final reports for abdominal imaging studies without a liver lesion < 0.5 cm, cystic kidney lesion < 1.0 cm or adrenal lesion < 1.0 cm noted

•

en:documentation that the patient is not on daily aspirin or anti-platelet regimen

•

en:documentation of reason(s) for not documenting a preoperative assessment (e.g., patient with a gynecologic or other pelvic malignancy noted at the time of surgery)

•

en:documentation of patient pain brought to a comfortable level within 48 hours from initial assessment

•

en:current cigarette smokers

•

en:specimen site other than anatomic location of lung or is not classified as non small cell lung cancer

•

en:rna testing for hepatitis c was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not given

•

en:patient was not referred to hospice care, reason not given

•

en:patient does not achieve final refraction (spherical equivalent) +/- 1.0 diopters of their planned refraction within 90 days of surgery, reason not given

•

en:patient did not start or is not receiving antiviral treatment for hepatitis c during the measurement period

•

en:patients with cardiac tamponade and/or pericardiocentesis occurring within 30 days

•

en:patients who abstained from smoking prior to anesthesia on the day of surgery or procedure

•

en:more than one ct scan of the paranasal sinuses ordered or received within 90 days after diagnosis

•

en:mapcp demonstration - community health teams

•

en:i intend to report the acute otitis externa (aoe) measures group

•

en:history of receiving blood transfusions prior to 1992

•

en:hepatitis c genotype testing documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c

•

en:elective surgical procedure

•

en:documentation that patient is a current tobacco user

•

en:documentation of viral load less than 200 copies/ml

•

en:documentation of patient stroke following cea

•

en:documentation of patient reason(s) for not prescribing beta-blocker therapy (eg, patient declined, other patient reasons)

•

en:biologic immune response modifier prescribed

•

en:aortic aneurysm 5.5 - 5.9 cm maximum diameter on centerline formatted ct or minor diameter on axial formatted ct

•

en:warfarin responsiveness testing by genetic technique using any method, any number of specimen(s)

•

en:voice functional limitation, discharge status at discharge from therapy or to end reporting

•

en:surgical site infection

•

en:rna testing for hepatitis c documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c

•

en:pediatric patient with minor blunt head trauma classified as low risk according to the pecarn prediction rules

•

en:patient with an initial phq-9 score greater than nine who did not achieve remission at twelve months as demonstrated by a twelve month (+/- 30 days) phq-9 score greater than or equal to five

•

en:patient sustained ureter injury at the time of surgery or discovered subsequently up to 1 month post-surgery

•

en:patient survey score did not improve from baseline following treatment

•

en:patient did not sustain ureter injury at the time of surgery or subsequently up to 1 month post-surgery

•

en:patient did not receive follow-up on or within 7 days after discharge

•

en:patient achieved an improvement in visual acuity, from their preoperative level, within 90 days of surgery

•

en:patients who had a follow-up evaluation conducted at least every three months during opioid therapy

•

en:patients who are not currently statin therapy users or did not receive an order (prescription) for statin therapy

•

en:one high-risk medication ordered

•

en:more than one ct scan of the paranasal sinuses ordered or received within 90 days after the date of diagnosis, reason not given

•

en:individual did not have a pdc of 0.8 or greater

•

en:final report documented that dicom format image data available to non-affiliated external healthcare facilities or entities on a secure, media free, reciprocally searchable basis with patient authorization for at least a 12-month period after the study

•

en:final reports for abdominal imaging studies with follow-up imaging recommended

•

en:documentation of patient death following cea

•

en:documentation of order for first or second generation cephalosporin for antimicrobial prophylaxis

•

en:documentation of end stage renal disease (esrd), dialysis, renal transplant or pregnancy

•

en:a transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is used

•

en:antibiotic regimen not prescribed within 10 days after onset of symptoms

•

en:advanced brain imaging (cta, ct, mra or mri) was ordered

•

en:admission to medicare care choice model program (mccm)

•

en:unplanned return to the operating room for a surgical procedure, for any reason, within 30 days of the principal operative procedure

•

en:symptomatic aaas that required urgent/emergent (non-elective) repair

•

en:spoken language expression functional limitation, discharge status at discharge from therapy or to end reporting

•

en:spoken language comprehension functional limitation, current status at therapy episode outset and at reporting intervals

•

en:services performed by care coordinator in the hospice setting, each 15 minutes

•

en:patient not evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soaap-r) or patient not interviewed at least once during opioid therapy

•

en:patient not admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision

•

en:p2y inhibitor prescribed at discharge

•

en:no return to the operating room for a surgical procedure, for any reason, within 30 days of the principal operative procedure

•

en:major amputation or open surgical bypass not required within 48 hours of the index endovascular lower extremity revascularization procedure

•

en:functional outcome assessment documented, care plan not documented, documentation the patient is not eligible for a care plan

•

en:final reports with documentation of one or more dose reduction techniques (e.g., automated exposure control, adjustment of the ma and/or kv according to patient size, use of iterative reconstruction technique)

•

en:dsm-ivtm criteria for major depressive disorder documented at the initial evaluation

•

en:documentation of patient with one or more complications or mortality within 30 days

•

en:documentation of patient reason(s) for not receiving one-time screening for hcv infection (e.g., patient declined, other patient reasons)

•

en:documentation of medical reason(s) that follow-up imaging is not indicated (e.g., patient has a known malignancy that can metastasize, other medical reason(s)

•

en:documentation of medical reason(s) for not prescribing a beta-lactam antibiotic (e.g., allergy, intolerance to beta -lactam antibiotics)

•

en:ct scan of the paranasal sinuses not ordered at the time of diagnosis or received within 28 days after date of diagnosis

•

en:count of previous ct (any type of ct) and cardiac nuclear medicine (myocardial perfusion) studies documented in the 12-month period prior to the current study

•

en:all quality actions for the applicable measures in the general surgery measures group have been performed for this patient

•

en:within the past 2 years, central dual-energy x-ray absorptiometry (dxa) not ordered or documented

•

en:specimen site other than anatomic location of lung or classified as nsclc-nos

•

en:services performed by other counselor in the hospice setting, each 15 minutes

•

en:patient with minor blunt head trauma did not have an appropriate indication(s) for a head ct

•

en:patient receiving maintenance hemodialysis for greater than or equal to 90 days without a catheter as the mode of vascular access

•

en:patients with clinical ascvd diagnosis

•

en:patients with a normal neurological examination

•

en:mapcp demonstration - physician incentive pool

•

en:major amputation or open surgical bypass required within 48 hours of the index endovascular lower extremity revascularization procedure

•

en:imaging study named according to standardized nomenclature

•

en:documentation of screening for uterine malignancy or those that had an ultrasound and/or endometrial sampling of any kind

•

en:documentation of patient discharged to home later than post-operative day 2 following cas

•

en:documentation of medical reason(s) for not prescribing beta-blocker therapy (eg, allergy, intolerance, other medical reasons)

•

en:documentation of active injection drug use

•

en:antiretroviral therapy prescribed

•

en:influenza a (h1n1) and warfarin responsiveness testing

•

en:within the past 2 years, central dual-energy x-ray absorptiometry (dxa) not ordered and documented, no review of systems and no medication history or pharmacologic therapy (other than minerals/vitamins) for osteoporosis prescribed

•

en:voice functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:spoken language comprehension functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:sinusitis caused by, or presumed to be caused by, bacterial infection

•

en:patient with an initial phq-9 score greater than nine who was not assessed for remission at twelve months (+/- 30 days)

•

en:patient did not receive follow-up on the date of discharge or within 30 days after discharge

•

en:patient did not have at least one medical visit in each 6 month period of the 24 month measurement period, with a minimum of 60 days between medical visits

•

en:patients who had the prophylactic antibiotic completely infused prior to the inflation of the proximal tourniquet

•

en:other speech language pathology functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:index date phq-score greater than 9 documented during the twelve month denominator identification period

•

en:hepatitis c quantitative rna testing documented as performed between 4-12 weeks after the initiation of antiviral treatment

•

en:final reports for abdominal imaging studies with follow-up imaging not recommended

•

en:filter removed within 3 months of placement

•

en:elective delivery or early induction not performed

•

en:documented re-assessment for the appropriateness of filter removal within 3 months of placement

•

en:documentation that the patient is not on a statin medication

•

en:documentation of medical reason(s) for not screening for unhealthy alcohol use (e.g., limited life expectancy, other medical reasons)

•

en:documentation of medical reason(s) for not including documentation that follow up imaging is not needed (e.g., patient has multiple endocrine neoplasia, patient has cervical lymphadenopathy, other medical reason(s))

•

en:currently a tobacco non-user

•

en:a transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is not used

•

en:aspirin prescribed at discharge

•

en:antibiotic regimen prescribed within 10 days after onset of symptoms for documented medical reason

•

en:all quality actions for the applicable measures in the optimizing patient exposure to ionizing radiation measures group have been performed for this patient

•

en:psoriasis assessment tool documented meeting any one of the specified benchmarks (e.g., (pga; 6-point scale), body surface area (bsa), psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi))

•

en:patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method

•

en:patient did not sustained bladder injury at the time of surgery or subsequently up to 1 month post-surgery

•

en:patient did not achieve an improvement in visual acuity, from their preoperative level, within 90 days of surgery, reason not given

•

en:no surgical site infection

•

en:national committee for quality assurance - level 3 medical home

•

en:i intend to report the general surgery measures group

•

en:follow-up recommendations not documented according to recommended guidelines for incidentally detected pulmonary nodules, reason not given

•

en:evaluation for wheelchair requiring face to face visit with physician

•

en:dsm-iv-tr criteria for major depressive disorder not documented at the initial evaluation, reason not otherwise specified

•

en:documentation of system reason(s) for not prescribing beta-blocker therapy (eg, other reasons attributable to the health care system)

•

en:documentation of patient survival in the hospital following endovascular aaa repair

•

en:documentation of medical reason(s) for not offering assistance with end of life issues (eg, patient in hospice and in terminal phase) during the measurement period

•

en:ct studies performed reported to a radiation dose index registry with all necessary data elements

•

en:count of previous ct and cardiac nuclear medicine (myocardial perfusion) studies not documented in the 12-month period prior to the current study, reason not given

•

en:any fasting or direct ldl-c laboratory test result = 190 mg/dl

•

en:total number of emergency department visits and inpatient hospitalizations less than two in the past 12 months

•

en:specimen site other than anatomic location of lung, is not classified as non small cell lung cancer or classified as nsclc-nos

•

en:remission at twelve months not demonstrated by a twelve month (+/-30 days) phq-9 score of less than five; either phq-9 score was not assessed or is greater than or equal to 5

•

en:remission at six months not demonstrated by a six month (+/-30 days) phq-9 score of less than five; either phq-9 score was not assessed or is greater than or equal to five

•

en:prophylactic antibiotic not completely infused prior to the inflation of the proximal tourniquet, reason not given

•

en:pneumococcal screening performed and documentation of vaccination received prior to discharge

•

en:patient did not sustain major viscus injury at the time of surgery or subsequently up to 1 month post-surgery

•

en:patient achieves final refraction (spherical equivalent) +/- 1.0 diopters of their planned refraction within 90 days of surgery

•

en:patients without cardiac tamponade and/or pericardiocentesis occurring within 30 days

•

en:patients who are not evaluated for venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure including (e.g., history of dvt, pe, mi, arrhythmia and stroke, reason not given)

•

en:pathology report includes the pt category and a statement on thickness and ulceration and for pt1, mitotic rate

•

en:operative report does not identify the prosthetic implant specifications including the prosthetic implant manufacturer, the brand name of the prosthetic implant and the size of each prosthetic implant, reason not given

•

en:imaging study not named according to standardized nomenclature, reason not given

•

en:documentation of patient with pain not brought to a comfortable level within 48 hours from initial assessment

•

en:documentation of patient death in the hospital following endovascular aaa repair

•

en:clinician documented reason patient was not able to complete 7 day follow-up from acute inpatient setting discharge (i.e patient death prior to follow-up visit, patient non-compliance for visit follow-up)

•

en:attention functional limitation, discharge status at discharge from therapy or to end reporting

•

en:unplanned rupture of the posterior capsule requiring vitrectomy during cataract surgery

•

en:spoken language expression functional limitation, current status at therapy episode outset and at reporting intervals

•

en:services performed by chaplain in the hospice setting, each 15 minutes

•

en:pneumococcal vaccination not administered prior to discharge, reason not specified

•

en:pcp prophylaxis was not prescribed within 3 months of low cd4+ cell count below 200 cells/mm3, reason not given

•

en:patient was referred to hospice care

•

en:patient is not eligible (e.g., patient death during procedure, absent urethra or an otherwise inaccessible bladder)

•

en:patients who did not abstain from smoking prior to anesthesia on the day of surgery or procedure

•

en:no documentation of negative or managed positive tb screen

•

en:national committee for quality assurance - level 1 medical home

•

en:elective delivery or early induction performed

•

en:documentation that patient is a current non-tobacco user

•

en:documentation of patient survival and absence of stroke following cas

•

en:documentation of patient reason(s) for not receiving annual screening for hcv infection (e.g., patient declined, other patient reasons)

•

en:documentation of medical reason for not performing foot exam (i.e., patients who have had either a bilateral amputation above or below the knee, or both a left and right amputation above or below the knee before or during the measurement period)

•

en:documentation of medical reason(s) for not reporting the histological type or nsclc-nos classification with an explanation (e.g., a solitary fibrous tumor in a person with a history of non-small cell carcinoma or other documented medical reasons)

•

en:blood pressure has a systolic value of < 140 and a diastolic value of < 90

•

en:attention functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:asthma not well-controlled based on the act, c-act, acq, or ataq score, or specified asthma control tool not used, reason not given

•

en:amoxicillin, with or without clavulanate, not prescribed as first line antibiotic at the time of diagnosis, reason not given

•

en:voice functional limitation, current status at therapy episode outset and at reporting intervals

•

en:statin not prescribed at discharge

•

en:patient with an initial phq-9 score greater than nine who achieves remission at twelve months as demonstrated by a twelve month (+/- 30 days) phq-9 score of less than five

•

en:patient whose mode of vascular access is a catheter at the time maintenance hemodialysis is initiated

•

en:patient taking tamsulosin hydrochloride

•

en:patient received follow-up within 7 days from discharge

•

en:patient not screened for unhealthy alcohol screening using a systematic screening method or patient did not receive brief counseling, reason not given

•

en:patients with documented shared decision-making including discussion of conservative (non-surgical) therapy (e.g., nsaids, analgesics, weight loss, exercise, injections) prior to the procedure

•

en:order for anti-platelet agents or p2y12 antagonists was not documented, reason not otherwise specified

•

en:one-time screening for hcv infection not received within 12 month reporting period and no documentation of prior screening for hcv infection, reason not given

•

en:no documentation of signed an opioid treatment agreement at least once during opioid therapy

•

en:intraoperative cystoscopy not performed to evaluate for lower tract injury

•

en:improvement in median time from ed arrival to initial ed oral or parenteral pain medication administration performed for ed admitted patients

•

en:final reports for ct or mri of the chest or neck or ultrasound of the neck with follow-up imaging not recommended

•

en:documentation of reason for not detecting adenoma(s) or other neoplasm. (e.g., neoplasm detected is only diagnosed as traditional serrated adenoma, sessile serrated polyp, or sessile serrated adenoma

•

en:documentation of reason(s) for not screening for uterine malignancy (e.g., prior hysterectomy)

•

en:chlamydia, gonorrhea, and syphilis not screened, due to documented reason (patient refusal is the only allowed exclusion)

•

en:aspirin not prescribed at discharge

•

en:unplanned hospital readmission within 30 days of principal procedure

•

en:seen pre-operatively by anesthesiologist or proxy prior to the day of surgery

•

en:screening for hcv infection not received within the 12 month reporting period, reason not given

•

en:previously diagnosed or have an active diagnosis of clinical ascvd

•

en:patient required a return to the operating room within 90 days of surgery

•

en:patient not receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 60 or greater consecutive days or a single prescription equating to 600 mg prednisone or greater for all fills

•

en:patient had one dose of meningococcal vaccine on or between the patient's 11th and 13th birthdays

•

en:operative report identifies the prosthetic implant specifications including the prosthetic implant manufacturer, the brand name of the prosthetic implant and the size of each prosthetic implant

•

en:intraoperative cystoscopy performed to evaluate for lower tract injury

•

en:foot exam was not performed, reason not given

•

en:at least two different high-risk medications ordered

•

en:aortic aneurysm 6.0 cm or greater maximum diameter on centerline formatted ct or minor diameter on axial formatted ct

•

en:all quality actions for the applicable measures in the sinusitis measures group have been performed for this patient

•

en:tobacco assessment or tobacco cessation intervention not performed, reason not given

•

en:services performed by other qualified therapist in the hospice setting, each 15 minutes

•

en:patient not offered assistance with end of life issues during the measurement period

•

en:patient has not been treated with a systemic or biologic medication for psoriasis for at least six months

•

en:patient has a valid reason for a head ct for trauma being ordered, regardless of indications (ie, ventricular shunt, brain tumor, coagulopathy, including thrombocytopenia)

•

en:patient had at least one medical visit in each 6 month period of the 24 month measurement period, with a minimum of 60 days between medical visits

•

en:p2y inhibitor not prescribed at discharge

•

en:other speech language pathology functional limitation, current status at therapy episode outset and at reporting intervals

•

en:non small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type or classified as nsclc-nos with an explanation

•

en:intervention for presence of leak of endoluminal contents through an anastomosis not required

•

en:final reports for ct or mri studies of the chest or neck or ultrasound of the neck without a thyroid nodule < 1.0 cm noted

•

en:door to puncture time of greater than 2 hours, no reason given

•

en:documentation of patient without one or more complications and without mortality within 30 days

•

en:documentation of patient death following cas

•

en:antiretroviral thereapy not prescribed

•

en:antibiotic regimen prescribed

•

en:all quality actions for the applicable measures in the total knee replacement measures group have been performed for this patient

•

cancer

•

en:radiation exposure indices, exposure time or number of fluorographic images in final report for procedures using fluoroscopy, documented

•

en:pneumocystis jiroveci pneumonia prophylaxis prescribed within 3 months of low cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15%

•

en:patient received follow-up on the date of discharge or within 30 days after discharge

•

en:patient discharge to home no later than post-operative day #7

•

en:other speech language pathology functional limitation, discharge status at discharge from therapy or to end reporting

•

en:order for first or second generation cephalosporin for antimicrobial prophylaxis was not documented, reason not given

•

en:no unplanned rupture of the posterior capsule requiring vitrectomy during cataract surgery

•

en:i intend to report the optimizing patient exposure to ionizing radiation measures group

•

en:intent for potential removal at time of placement

•

en:documentation of planned hybrid or staged procedure

•

en:documentation of patient without one or more complications within 90 days

•

en:documentation of patient stroke following cas

•

en:documentation of medical reason(s) for not completely infusing the prophylactic antibiotic prior to the inflation of the proximal tourniquet (e.g., a tourniquet was not used)

•

en:beta-blocker therapy prescribed or currently being taken

•

en:all quality actions for the applicable measures in the multiple chronic conditions measures group have been performed for this patient

•

en:all quality actions for the applicable measures in the aoe measures group have been performed for this patient

•

en:services performed by dietary counselor in the hospice setting, each 15 minutes

•

en:screening performed and documentation that vaccination not indicated/patient refusal

•

en:radiation exposure indices, exposure time or number of fluorographic images not documented in final report for procedure using fluoroscopy, reason not given

•

en:pneumocystis jiroveci pneumonia prophylaxis prescribed wthin 3 months of low cd4+ cell count below 200 cells/mm3

•

en:patient survey score improved from baseline following treatment

•

en:patient discontinued from hemodialysis or peritoneal dialysis

•

en:patient did not undergo abdominal imaging and did not have a documented reason for not undergoing abdominal imaging in the reporting period

•

en:patients with 90 day mrs score of 0 to 2

•

en:patients who have received or are receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 60 or greater consecutive days or a single prescription equating to 600 mg prednisone or greater for all fills

•

en:patients who did not have a follow-up evaluation conducted at least every three months during opioid therapy

•

en:mapcp demonstration - state provided services

•

en:i intend to report the multiple chronic conditions measures group

•

en:i intend to report the diabetic retinopathy measures group

•

en:door to puncture time of less than 2 hours

•

en:documentation of post-surgical anatomy (e.g., right hemicolectomy, ileocecal resection, etc.)

•

en:documentation of negative or managed positive tb screen with further evidence that tb is not active

•

en:documentation of a ct scan of the paranasal sinuses ordered at the time of diagnosis or received within 28 days after date of diagnosis

•

en:documentation of an order for anti-platelet agents or p2y12 antagonists

•

en:remission at twelve months as demonstrated by a twelve month (+/-30 days) phq-9 score of less than 5

•

en:patient evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soaap-r) or patient interviewed at least once during opioid therapy

•

en:patients who have ever had a fasting or direct laboratory result of ldl-c = 190 mg/dl

•

en:no photodocumentation of cecal landmarks to establish a complete examination

•

en:monitored anesthesia care (mac)

•

en:i intend to report the total knee replacement measures group

•

en:i intend to report the cardiovascular prevention measures group

•

en:intervention for presence of leak of endoluminal contents through an anastomosis required

•

en:index date phq-9 score greater than 9 documented during the twelve month denominator identification period

•

en:hepatitis c genotype testing was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not given

•

en:documented reason for not assessing hepatitis b virus (hbv) status (e.g. patient not receiving a first course of anti-tnf therapy, patient declined) within one year prior to first course of anti-tnf therapy

•

en:documentation of viral load equal to or greater than 200 copies/ml or viral load not performed

•

en:documentation of patient reason(s) for not referring to hospice care (e.g., patient declined, other patient reasons)

•

en:documentation amoxicillin, with or without clavulanate, prescribed as a first line antibiotic at the time of diagnosis

•

en:clinician treating major depressive disorder did not communicate to clinician treating comorbid condition for specified patient reason

•

en:clinician documented reason patient was not able to complete 30 day follow-up from acute inpatient setting discharge (e.g., patient death prior to follow-up visit, patient non-compliant for visit follow-up)

•

en:chlamydia, gonorrhea, and syphilis not screened, reason not given

•

en:antibiotic regimen prescribed within10 days after onset of symptoms

•

en:primary non-small cell lung cancer biopsy and cytology specimen report does not document classification into specific histologic type or classified as nsclc-nos with an explanation

•

en:post-partum screenings, evaluations and education performed

•

en:patient who had a diagnosis of bipolar disorder or personality disorder, death, permanent nursing home resident or receiving hospice or palliative care any time during the measurement or assessment period

•

en:patient survey results not available

•

en:patient starting antiviral treatmentfor hepatitis c during the measurement period

•

en:patient received screening for hcv infection within the 12 month reporting period

•

en:patient presented within 24 hours of a minor blunt head trauma with a gcs score of 15 and had a head ct ordered for trauma by an emergency care provider

•

en:patient not treated with a beta-lactam antibiotic as definitive therapy, reason not given

•

en:patient is not eligible (e.g., gynecologic or other pelvic malignancy documented, concurrent surgery involving bladder neoplasia or otherwise to treat a bladder specific problem, patient death from other causes, etc.)

•

en:patient alive 3 months post procedure

•

en:no unplanned hospital readmission within 30 days of principal procedure

•

en:memory functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:memory functional limitation, current status at therapy episode outset and at reporting intervals

•

en:hepatitis c quantitative rna testing was not documented as performed between 4-12 weeks after the initiation of antiviral treatment, reason not given

•

en:follow-up recommendations documented according to recommended guidelines for incidentally detected pulmonary nodules (e.g., follow-up ct imaging studies needed or that no follow-up is needed) based at a minimum on nodule size and patient risk factors

•

en:documentation of system reason(s) for ordering an advanced brain imaging study (i.e., needed as part of a clinical trial; other clinician ordered the study)

•

en:documentation of signed opioid treatment agreement at least once during opioid therapy

•

en:documentation of medical reason(s) for not reporting pt category and a statement on thickness and ulceration and for pt1, mitotic rate (e.g., negative skin biopsies in a patient with a history of melanoma or other documented medical reasons)

•

en:all quality actions for the applicable measures in the cardiovascular prevention measures group have been performed for this patient

•

biopsie

•

cellule

•

en:primary

•

intervention chirurgicale à froid

◀

‹

366

en:patient received one-time screening for hcv infection

•

en:rna testing for hepatitis c documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c

•

en:no surgical site infection

•

en:pneumocystis jiroveci pneumonia prophylaxis prescribed within 3 months of low cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15%

•

en:chlamydia, gonorrhea, and syphilis not screened, due to documented reason (patient refusal is the only allowed exclusion)

•

en:advanced brain imaging (cta, ct, mra or mri) was not ordered

•

en:documentation of patient pain brought to a comfortable level within 48 hours from initial assessment

•

en:aspirin not prescribed for documented reasons (e.g., allergy, medical intolerance, history of bleed)

•

intervention chirurgicale à froid

•

en:elective delivery or early induction performed

•

en:specimen site other than anatomic cutaneous location

•

en:no unplanned hospital readmission within 30 days of principal procedure

•

en:patient offered assistance with end of life issues during the measurement period

•

en:elective surgical procedure

•

en:patient discharge to home no later than post-operative day #7

•

en:motor speech functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:patient received follow-up on the date of discharge or within 30 days after discharge

•

en:patient with minor blunt head trauma had an appropriate indication(s) for a head ct

•

en:p2y inhibitor not prescribed at discharge

•

en:rna testing for hepatitis c was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not given

•

en:documented re-assessment for the appropriateness of filter removal within 3 months of placement

•

en:surgical site infection

•

en:antiretroviral therapy prescribed

•

en:antibiotic regimen prescribed within 10 days after onset of symptoms for documented medical reason

•

en:beta-blocker therapy not prescribed, reason not given

•

en:documentation of patient reason(s) for not receiving one-time screening for hcv infection (e.g., patient declined, other patient reasons)

•

en:final reports for ct or mri studies of the chest or neck or ultrasound of the neck without a thyroid nodule < 1.0 cm noted

•

en:major amputation or open surgical bypass not required within 48 hours of the index endovascular lower extremity revascularization procedure

•

en:more than one ct scan of the paranasal sinuses ordered or received within 90 days after diagnosis

•

en:non small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type or classified as nsclc-nos with an explanation

•

en:patients with cardiac tamponade and/or pericardiocentesis occurring within 30 days

•

en:patient not admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision

•

en:patient presented within 24 hours of a minor blunt head trauma with a gcs score of 15 and had a head ct ordered for trauma by an emergency care provider

•

en:patient received screening for hcv infection within the 12 month reporting period

•

en:patient survey results not available

•

en:remission at six months not demonstrated by a six month (+/-30 days) phq-9 score of less than five; either phq-9 score was not assessed or is greater than or equal to five

•

en:spoken language expression functional limitation, discharge status at discharge from therapy or to end reporting

•

en:statin prescribed at discharge

•

en:voice functional limitation, current status at therapy episode outset and at reporting intervals

•

en:current cigarette smokers

•

en:documentation of at least two attempts to reach the patient to arrange a clinical re-assessment for the appropriateness of filter removal within 3 months of placement

•

en:history of injection drug use

•

en:imaging study named according to standardized nomenclature

•

en:improvement in median time from ed arrival to initial ed oral or parenteral pain medication administration not performed for ed admitted patients

•

en:intraoperative cystoscopy performed to evaluate for lower tract injury

•

en:i intend to report the general surgery measures group

•

en:major amputation or open surgical bypass required within 48 hours of the index endovascular lower extremity revascularization procedure

•

en:more than one ct scan of the paranasal sinuses ordered or received within 90 days after the date of diagnosis, reason not given

•

en:no documentation of negative or managed positive tb screen

•

en:no photodocumentation of cecal landmarks to establish a complete examination

•

en:p2y inhibitor not prescribed for documented reasons (e.g., allergy, medical intolerance, history of bleed)

•

en:patients who are not currently statin therapy users or did not receive an order (prescription) for statin therapy

•

en:patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method

•

en:previously diagnosed or have an active diagnosis of clinical ascvd

•

en:remission at six months as demonstrated by a six month (+/-30 days) phq-9 score of less than five

•

en:statin not prescribed for documented reasons (e.g., allergy, medical intolerance)

•

en:unplanned hospital readmission within 30 days of principal procedure

•

en:i intend to report the sinusitis measures group

•

en:patients without cardiac tamponade and/or pericardiocentesis occurring within 30 days

•

en:currently a tobacco non-user

•

en:documentation of medical reason(s) that follow-up imaging is not indicated (e.g., patient has a known malignancy that can metastasize, other medical reason(s)

•

en:documentation of negative or managed positive tb screen with further evidence that tb is not active

•

en:improvement in median time from ed arrival to initial ed oral or parenteral pain medication administration performed for ed admitted patients

•

en:index date phq-score greater than 9 documented during the twelve month denominator identification period

•

en:intervention for presence of leak of endoluminal contents through an anastomosis not required

•

en:intraoperative cystoscopy not performed to evaluate for lower tract injury

•

en:i intend to report the multiple chronic conditions measures group

•

en:mapcp demonstration - state provided services

•

en:memory functional limitation, current status at therapy episode outset and at reporting intervals

•

en:patients with documented shared decision-making including discussion of conservative (non-surgical) therapy (e.g., nsaids, analgesics, weight loss, exercise, injections) prior to the procedure

•

en:patient achieves final refraction (spherical equivalent) +/- 1.0 diopters of their planned refraction within 90 days of surgery

•

en:patient did not have at least one medical visit in each 6 month period of the 24 month measurement period, with a minimum of 60 days between medical visits

•

en:patient not treated with a beta-lactam antibiotic as definitive therapy, reason not given

•

en:patient with an initial phq-9 score greater than nine who was not assessed for remission at twelve months (+/- 30 days)

•

en:pneumocystis jiroveci pneumonia prophylaxis prescribed wthin 3 months of low cd4+ cell count below 200 cells/mm3

•

en:specimen site other than anatomic location of lung or is not classified as non small cell lung cancer

•

en:statin not prescribed at discharge

•

en:symptomatic aaas that required urgent/emergent (non-elective) repair

•

en:total number of emergency department visits and inpatient hospitalizations less than two in the past 12 months

•

en:antibiotic regimen not prescribed within 10 days after onset of symptoms

•

en:antibiotic regimen prescribed within10 days after onset of symptoms

•

en:any fasting or direct ldl-c laboratory test result = 190 mg/dl

•

en:attention functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:chlamydia, gonorrhea, and syphilis not screened, reason not given

•

en:documentation amoxicillin, with or without clavulanate, prescribed as a first line antibiotic at the time of diagnosis

•

en:final reports for abdominal imaging studies with follow-up imaging recommended

•

en:hepatitis c genotype testing was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not given

•

en:intent for potential removal at time of placement

•

en:i intend to report the optimizing patient exposure to ionizing radiation measures group

•

en:patient evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soaap-r) or patient interviewed at least once during opioid therapy

•

en:patient had one dose of meningococcal vaccine on or between the patient's 11th and 13th birthdays

•

en:patient starting antiviral treatment for hepatitis c during the measurement period

•

en:patient whose mode of vascular access is not a catheter at the time maintenance hemodialysis is initiated

•

en:photodocumentation of one or more cecal landmarks to establish a complete examination

•

en:radiation exposure indices, exposure time or number of fluorographic images in final report for procedures using fluoroscopy, documented

•

en:services performed by other counselor in the hospice setting, each 15 minutes

•

en:patient sustained ureter injury at the time of surgery or discovered subsequently up to 1 month post-surgery

•

en:documentation that the patient is not on daily aspirin or anti-platelet regimen

•

en:documentation of medical reason(s) for not completely infusing the prophylactic antibiotic prior to the inflation of the proximal tourniquet (e.g., a tourniquet was not used)

•

en:all quality actions for the applicable measures in the general surgery measures group have been performed for this patient

•

en:antibiotic regimen prescribed

•

en:aspirin prescribed at discharge

•

en:attention functional limitation, discharge status at discharge from therapy or to end reporting

•

en:biologic immune response modifier prescribed

•

en:ct studies performed not reported to a radiation dose index registry, reason not given

•

en:documentation of medical reason(s) for not screening for unhealthy alcohol use (e.g., limited life expectancy, other medical reasons)

•

en:documentation of patient reason(s) for not prescribing beta-blocker therapy (eg, patient declined, other patient reasons)

•

en:documentation of system reason(s) for ordering an advanced brain imaging study (i.e., needed as part of a clinical trial; other clinician ordered the study)

•

en:documentation of viral load less than 200 copies/ml

•

en:history of receiving blood transfusions prior to 1992

•

en:memory functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:patient did not undergo abdominal imaging and did not have a documented reason for not undergoing abdominal imaging in the reporting period

•

en:patient received follow-up within 7 days from discharge

•

en:prophylactic antibiotic not completely infused prior to the inflation of the proximal tourniquet, reason not given

•

en:radiation exposure indices, exposure time or number of fluorographic images not documented in final report for procedure using fluoroscopy, reason not given

•

en:screening performed and documentation that vaccination not indicated/patient refusal

•

en:services performed by dietary counselor in the hospice setting, each 15 minutes

•

en:sinusitis caused by, or presumed to be caused by, bacterial infection

•

en:transfer of care during an anesthetic or to the intensive care unit

•

en:all quality actions for the applicable measures in the sinusitis measures group have been performed for this patient

•

en:asthma not well-controlled based on the act, c-act, acq, or ataq score, or specified asthma control tool not used, reason not given

•

en:documentation of active injection drug use

•

en:documentation of patient survival and absence of stroke following cas

•

en:documentation of reason(s) for not documenting a preoperative assessment (e.g., patient with a gynecologic or other pelvic malignancy noted at the time of surgery)

•

en:index date phq-9 score greater than 9 documented during the twelve month denominator identification period

•

en:individual did not have a pdc of 0.8 or greater

•

en:patients who had a follow-up evaluation conducted at least every three months during opioid therapy

•

en:patient has been treated with a systemic or biologic medication for psoriasis for at least six months

•

en:total number of emergency department visits and inpatient hospitalizations equal to or greater than two in the past 12 months or patient not screened, reason not given

•

en:patients who had the prophylactic antibiotic completely infused prior to the inflation of the proximal tourniquet

•

en:all quality actions for the applicable measures in the cardiovascular prevention measures group have been performed for this patient

•

en:antiretroviral thereapy not prescribed

•

en:blood pressure has a systolic value of =140 and a diastolic value of = 90 or systolic value < 140 and diastolic value = 90 or systolic value = 140 and diastolic value < 90

•

en:chlamydia, gonorrhea and syphilis screening results documented (report when results are present for all of the 3 screenings)

•

en:documentation of reason(s) for not screening for uterine malignancy (e.g., prior hysterectomy)

•

en:final reports for abdominal imaging studies with follow-up imaging not recommended

•

en:incidental thyroid nodule < 1.0 cm noted in report

•

en:patient did not start or is not receiving antiviral treatment for hepatitis c during the measurement period

•

en:patient has not been treated with a systemic or biologic medication for psoriasis for at least six months

•

en:amoxicillin, with or without clavulanate, not prescribed as first line antibiotic at the time of diagnosis, reason not given

•

en:count of previous ct and cardiac nuclear medicine (myocardial perfusion) studies not documented in the 12-month period prior to the current study, reason not given

•

en:documentation of patient death following cea

•

en:documentation of patient with one or more complications within 90 days

•

en:dsm-iv-tr criteria for major depressive disorder not documented at the initial evaluation, reason not otherwise specified

•

en:final reports for ct or mri of the chest or neck or ultrasound of the neck with follow-up imaging recommended

•

en:i intend to report the cardiovascular prevention measures group

•

en:motor speech functional limitation, discharge status, at discharge from therapy or to end reporting

•

en:national committee for quality assurance - level 3 medical home

•

en:patient not discharged to home by post-operative day #7

•

en:patient required a return to the operating room within 90 days of surgery

•

en:remission at twelve months as demonstrated by a twelve month (+/-30 days) phq-9 score of less than 5

•

en:spoken language expression functional limitation, current status at therapy episode outset and at reporting intervals

•

cancer

•

en:all necessary data elements not included, reason not given

•

en:aortic aneurysm 5.5 - 5.9 cm maximum diameter on centerline formatted ct or minor diameter on axial formatted ct

•

en:asthma well-controlled based on the act, c-act, acq, or ataq score and results documented

•

en:documentation of medical reason(s) for not prescribing a beta-lactam antibiotic (e.g., allergy, intolerance to beta -lactam antibiotics)

•

en:documentation of patient survival and absence of stroke following cea

•

en:documentation of signed opioid treatment agreement at least once during opioid therapy

•

en:documentation that the patient is not on a statin medication

•

en:hepatitis c genotype testing documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c

•

en:i intend to report the diabetic retinopathy measures group

•

en:one-time screening for hcv infection not received within 12 month reporting period and no documentation of prior screening for hcv infection, reason not given

•

en:one high-risk medication not ordered

•

en:patient receiving maintenance hemodialysis for greater than or equal to 90 days with a catheter as the mode of vascular access

•

en:patient sustained major viscus injury at the time of surgery or subsequently up to 1 month post-surgery

•

en:patient was not referred to hospice care, reason not given

•

en:patient whose mode of vascular access is a catheter at the time maintenance hemodialysis is initiated

•

en:post-partum screenings, evaluations and education performed

•

en:primary non-small cell lung cancer biopsy and cytology specimen report does not document classification into specific histologic type or classified as nsclc-nos with an explanation

•

en:all quality actions for the applicable measures in the diabetic retinopathy measures group have been performed for this patient

•

en:aortic aneurysm 6.0 cm or greater maximum diameter on centerline formatted ct or minor diameter on axial formatted ct

•

en:at least two different high-risk medications ordered

•

en:documentation of medical reason(s) for not offering assistance with end of life issues (eg, patient in hospice and in terminal phase) during the measurement period

•

en:documentation of patient survival in the hospital following endovascular aaa repair

•

en:documentation of planned hybrid or staged procedure

•

en:memory functional limitation, discharge status at discharge from therapy or to end reporting

•

en:patient achieved an improvement in visual acuity, from their preoperative level, within 90 days of surgery

•

en:patient did not sustained bladder injury at the time of surgery or subsequently up to 1 month post-surgery

•

en:patient is not eligible (e.g., patient death during procedure, absent urethra or an otherwise inaccessible bladder)

•

en:patient receiving maintenance hemodialysis for greater than or equal to 90 days without a catheter as the mode of vascular access

•

en:patient sustained bladder injury at the time of surgery or subsequently up to 1 month post-surgery

•

en:spoken language expression functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:all quality actions for the applicable measures in the optimizing patient exposure to ionizing radiation measures group have been performed for this patient

•

en:documentation of patient discharged to home no later than post operative day 2 following cas

•

en:documentation of patient without one or more complications and without mortality within 30 days

•

en:documentation of post-surgical anatomy (e.g., right hemicolectomy, ileocecal resection, etc.)

•

en:hepatitis c quantitative rna testing was not documented as performed between 4-12 weeks after the initiation of antiviral treatment, reason not given

•

en:patient starting antiviral treatmentfor hepatitis c during the measurement period

•

en:pneumococcal screening performed and documentation of vaccination received prior to discharge

•

en:remission at twelve months not demonstrated by a twelve month (+/-30 days) phq-9 score of less than five; either phq-9 score was not assessed or is greater than or equal to 5

•

en:voice functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:a transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is used

•

en:documentation of patient discharged to home later than post-operative day 2 following cas

•

en:documentation that patient is a current non-tobacco user

•

en:evaluation for wheelchair requiring face to face visit with physician

•

en:mapcp demonstration - physician incentive pool

•

en:monitored anesthesia care (mac)

•

en:non small cell lung cancer biopsy and cytology specimen report does not document classification into specific histologic type or classified as nsclc-nos with an explanation

•

en:no unplanned rupture of the posterior capsule requiring vitrectomy during cataract surgery

•

en:one ct scan or no ct scan of the paranasal sinuses ordered within 90 days after the date of diagnosis

•

en:patient not screened for uterine malignancy, or those that have not had an ultrasound and/or endometrial sampling of any kind, reason not given

•

en:patient survey score did not improve from baseline following treatment

•

en:patient with an initial phq-9 score greater than nine who did not achieve remission at twelve months as demonstrated by a twelve month (+/- 30 days) phq-9 score greater than or equal to five

•

en:pediatric patient with minor blunt head trauma classified as low risk according to the pecarn prediction rules

•

en:prior thyroid disease diagnosis

•

en:transesophageal doppler measurement of cardiac output (including probe placement, image acquisition, and interpretation per course of treatment) for monitoring purposes

•

en:unplanned rupture of the posterior capsule requiring vitrectomy during cataract surgery

•

en:all quality actions for the applicable measures in the total knee replacement measures group have been performed for this patient

•

en:ct scan of the paranasal sinuses not ordered at the time of diagnosis or received within 28 days after date of diagnosis

•

en:documentation of an order for anti-platelet agents or p2y12 antagonists

•

en:documentation of patient death following cas

•

en:elective delivery or early induction not performed

•

en:patients who did not have a follow-up evaluation conducted at least every three months during opioid therapy

•

en:patient not screened for unhealthy alcohol screening using a systematic screening method or patient did not receive brief counseling, reason not given

•

en:patient treated with a beta-lactam antibiotic as definitive therapy

•

en:patient with an initial phq-9 score greater than nine who achieves remission at twelve months as demonstrated by a twelve month (+/- 30 days) phq-9 score of less than five

•

en:preoperative assessment not documented, reason not given

•

en:services performed by other qualified therapist in the hospice setting, each 15 minutes

•

en:services performed by volunteer in the hospice setting, each 15 minutes

•

en:unplanned return to the operating room for a surgical procedure, for any reason, within 30 days of the principal operative procedure

•

en:advanced brain imaging (cta, ct, mra or mri) was ordered

•

en:all quality actions for the applicable measures in the multiple chronic conditions measures group have been performed for this patient

•

en:attention functional limitation, current status at therapy episode outset and at reporting intervals

•

en:beta-blocker therapy prescribed or currently being taken

•

en:clinician treating major depressive disorder did not communicate to clinician treating comorbid condition for specified patient reason

•

en:documentation of patient reason(s) for not receiving annual screening for hcv infection (e.g., patient declined, other patient reasons)

•

en:i intend to report the total knee replacement measures group

•

en:national committee for quality assurance - level 1 medical home

•

en:patients in whom mrs score could not be obtained at 90 day follow-up

•

en:patients who are currently statin therapy users or received an order (prescription) for statin therapy

•

en:patients who were born in the years 1945-1965

•

en:patient transferred directly from anesthetizing location to pacu

•

en:patient underwent abdominal imaging with ultrasound, contrast enhanced ct or contrast mri for hcc

•

en:pcp prophylaxis was not prescribed within 3 months of low cd4+ cell count below 200 cells/mm3, reason not given

•

en:post-partum screenings, evaluations and education not performed

•

en:seen pre-operatively by anesthesiologist or proxy prior to the day of surgery

•

en:specimen site other than anatomic location of lung or classified as nsclc-nos

•

en:spoken language comprehension functional limitation, discharge status, at discharge from therapy or to end reporting

•

en:voice functional limitation, discharge status at discharge from therapy or to end reporting

•

en:warfarin responsiveness testing by genetic technique using any method, any number of specimen(s)

•

en:biopsy

•

en:documentation of a ct scan of the paranasal sinuses ordered at the time of diagnosis or received within 28 days after date of diagnosis

•

en:documentation of patient death in the hospital following endovascular aaa repair

•

en:documentation of patient stroke following cea

•

en:dsm-ivtm criteria for major depressive disorder documented at the initial evaluation

•

en:final reports for ct or mri of the chest or neck or ultrasound of the neck with follow-up imaging not recommended

•

en:i intend to report the acute otitis externa (aoe) measures group

•

en:national committee for quality assurance - level 2 medical home

•

en:order for anti-platelet agents or p2y12 antagonists was not documented, reason not otherwise specified

•

en:other speech language pathology functional limitation, current status at therapy episode outset and at reporting intervals

•

en:p2y inhibitor prescribed at discharge

•

en:patient alive 3 months post procedure

•

en:patient had at least one medical visit in each 6 month period of the 24 month measurement period, with a minimum of 60 days between medical visits

•

en:patient survey score improved from baseline following treatment

•

en:admission to medicare care choice model program (mccm)

•

en:blood pressure has a systolic value of < 140 and a diastolic value of < 90

•

en:documentation of medical reason(s) for not prescribing beta-blocker therapy (eg, allergy, intolerance, other medical reasons)

•

en:documentation of patient without one or more complications within 90 days

•

en:documentation of viral load equal to or greater than 200 copies/ml or viral load not performed

•

en:follow-up recommendations not documented according to recommended guidelines for incidentally detected pulmonary nodules, reason not given

•

en:patients who did not abstain from smoking prior to anesthesia on the day of surgery or procedure

•

en:patients with 90 day mrs score greater than 2

•

en:patient admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision

•

en:patient did not achieve an improvement in visual acuity, from their preoperative level, within 90 days of surgery, reason not given

•

en:patient did not have one dose of meningococcal vaccine on or between the patient's 11th and 13th birthdays

•

en:patient did not require a return to the operating room within 90 days of surgery

•

en:patient did not sustain ureter injury at the time of surgery or subsequently up to 1 month post-surgery

•

en:patient with minor blunt head trauma did not have an appropriate indication(s) for a head ct

•

en:pneumococcal vaccination not administered prior to discharge, reason not specified

•

en:screening for hcv infection not received within the 12 month reporting period, reason not given

•

en:the highest fasting or direct ldl-c laboratory test result of 70-189 mg/dl in the measurement period or two years prior to the beginning of the measurement period

•

en:within the past 2 years, central dual-energy x-ray absorptiometry (dxa) not ordered or documented

•

en:aspirin not prescribed at discharge

•

en:count of previous ct (any type of ct) and cardiac nuclear medicine (myocardial perfusion) studies documented in the 12-month period prior to the current study

•

en:documentation of patient with one or more complications or mortality within 30 days

•

en:door to puncture time of greater than 2 hours, no reason given

•

en:door to puncture time of less than 2 hours

•

en:hepatitis c quantitative rna testing documented as performed between 4-12 weeks after the initiation of antiviral treatment

•

en:individual had a pdc of 0.8 or greater

•

en:no documentation of signed an opioid treatment agreement at least once during opioid therapy

•

en:no return to the operating room for a surgical procedure, for any reason, within 30 days of the principal operative procedure

•

en:patients prescribed opiates for longer than six weeks

•

en:patient did not receive follow-up on the date of discharge or within 30 days after discharge

•

en:patient did not sustain major viscus injury at the time of surgery or subsequently up to 1 month post-surgery

•

en:patient has a valid reason for a head ct for trauma being ordered, regardless of indications (ie, ventricular shunt, brain tumor, coagulopathy, including thrombocytopenia)

•

en:patient taking tamsulosin hydrochloride

•

en:pediatric patient with minor blunt head trauma not classified as low risk according to the pecarn prediction rules

•

en:services performed by care coordinator in the hospice setting, each 15 minutes

•

en:spoken language comprehension functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:tobacco assessment or tobacco cessation intervention not performed, reason not given

•

en:influenza a (h1n1) and warfarin responsiveness testing

•

en:documentation of patient reason(s) for not referring to hospice care (e.g., patient declined, other patient reasons)

•

en:documentation of patient stroke following cas

•

en:documentation of screening for uterine malignancy or those that had an ultrasound and/or endometrial sampling of any kind

•

en:final reports for abdominal imaging studies without a liver lesion < 0.5 cm, cystic kidney lesion < 1.0 cm or adrenal lesion < 1.0 cm noted

•

en:one high-risk medication ordered

•

en:order for first or second generation cephalosporin for antimicrobial prophylaxis was not documented, reason not given

•

en:other speech language pathology functional limitation, discharge status at discharge from therapy or to end reporting

•

en:patient did not receive follow-up on or within 7 days after discharge

•

en:patient was referred to hospice care

•

en:services performed by qualified pharmacist in the hospice setting, each 15 minutes

•

en:specimen site other than anatomic location of lung or is not classified as primary non-small cell lung cancer

•

en:at least two different high-risk medications not ordered

•

en:a transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is not used

•

en:documentation of patient with pain not brought to a comfortable level within 48 hours from initial assessment

•

en:documentation that patient is a current tobacco user

•

en:filter removed within 3 months of placement

•

en:functional outcome assessment documented, care plan not documented, documentation the patient is not eligible for a care plan

•

en:imaging study not named according to standardized nomenclature, reason not given

•

en:mapcp demonstration - community health teams

•

en:other speech language pathology functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting

•

en:pathology report includes the pt category and a statement on thickness and ulceration and for pt1, mitotic rate

•

en:patients who abstained from smoking prior to anesthesia on the day of surgery or procedure

•

en:patients who are evaluated for venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure (e.g. history of dvt, pe, mi, arrhythmia and stroke)

•

en:patients with 90 day mrs score of 0 to 2

•

en:patient discontinued from hemodialysis or peritoneal dialysis

•

en:patient does not achieve final refraction (spherical equivalent) +/- 1.0 diopters of their planned refraction within 90 days of surgery, reason not given

•

en:patient not evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soaap-r) or patient not interviewed at least once during opioid therapy

•

en:patient not offered assistance with end of life issues during the measurement period

•

en:specimen site other than anatomic location of lung, is not classified as non small cell lung cancer or classified as nsclc-nos

•

en:spoken language comprehension functional limitation, current status at therapy episode outset and at reporting intervals

•

en:all quality actions for the applicable measures in the aoe measures group have been performed for this patient

•

en:ct studies performed reported to a radiation dose index registry with all necessary data elements

•

en:documentation of end stage renal disease (esrd), dialysis, renal transplant or pregnancy

•

en:documentation of order for first or second generation cephalosporin for antimicrobial prophylaxis

•

en:documentation of system reason(s) for not prescribing beta-blocker therapy (eg, other reasons attributable to the health care system)

•

en:foot exam was not performed, reason not given

•

en:incidental ct finding: liver lesion = 0.5 cm, cystic kidney lesion < 1.0 cm or adrenal lesion = 1.0 cm

•

en:intervention for presence of leak of endoluminal contents through an anastomosis required

•

en:operative report identifies the prosthetic implant specifications including the prosthetic implant manufacturer, the brand name of the prosthetic implant and the size of each prosthetic implant

•

en:pathology report does not include the pt category and a statement on thickness and ulceration and for pt1, mitotic rate

•

en:patients who have ever had a fasting or direct laboratory result of ldl-c = 190 mg/dl

•

en:patients with a normal neurological examination

•

en:patients with clinical ascvd diagnosis

•

en:patient identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method and received brief counseling

•

en:preoperative assessment documented

•

en:services performed by chaplain in the hospice setting, each 15 minutes

•

biopsie

•

Biopsie

◀

Génériques

[F] [H]

›

en:primary

• Mathieu Lafourcade • LIRMM (données libres en Creative Commons - C0 domaine public) •

• This page link : https://www.jeuxdemots.org/diko.php?gotermid=8128651 • caches: c1=8 c2=370 c3=367

+/-

♥

po

la

ti

le

as

ku

co

lo

to

ta

ta

xe

po

li

?!

!?

[Vider le cache]